Abstract
An RP-LC method has been developed for analysis of JS38 in the plasma, urine, bile, feces, and important tissues of rats. Chromatography was performed on a C18 analytical column with 80:20 (%, v/v) acetonitrile–phosphate buffer (0.5% phosphoric acid and 0.3% TEA adjusted to pH 5.0) as mobile phase at a flow-rate of 1.0 mL min−1. Eluted compounds were detected at 400 nm by ultraviolet diode-array detection (DAD). The method was validated for linearity, accuracy (recovery from biological matrixes such as plasma, urine, bile, feces, and important organs), repeatability (within-day and between-day precision), and stability. The results indicate that the method is suitable for pre-clinical pharmacokinetic study of JS38.
Similar content being viewed by others
References
Akita H, Doki Y, Miyata H (2006) J Surg Oncol 93(5):401–409. doi:10.1002/jso.20501
Yazici Y (2006) Rheumatology 45(3):361–366. doi:10.1093/rheumatology/kei199
Kathleen Parfitt (1999) Martindale—the complete drug reference. 32nd edn, p 547
Pharmacopeia US (2000) US Pharmacopeia 24 and National Formulary 19, Asian edn, pp 2231–2232
Yuan BJ, She JH, Lu GC (2007) J Toxicol 21(4):277–278 In Chinese
Liu K (2003) Chin Tradit Herbal Drugs 34(9):769–771 In Chinese
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhang, H., Fang, Y. & Li, Y. LC Analysis of JS38, a Novel Antineoplastic Medicine, in the Plasma, Urine, Bile, Feces, and Other Tissues of Rats. Chroma 68, 409–414 (2008). https://doi.org/10.1365/s10337-008-0736-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-008-0736-x